Holdings

Palo Alto Investors LP

As of Sep 30, 2026, Palo Alto Investors LP reported 49 positions worth US$628M. Largest: PTC Therapeutics, Inc., Iovance Biotherapeutics, Inc. and Insmed Incorporated. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
PTC Therapeutics, Inc.875KUS$56.7M−43,497Sep 30, 2026
Iovance Biotherapeutics, Inc.3.47MUS$51.4M−1.82MSep 30, 2026
Insmed Incorporated444KUS$50.6M+29,665Sep 30, 2026
ACADIA Pharmaceuticals Inc.2.49MUS$50.1M−378KSep 30, 2026
BioMarin Pharmaceutical Inc.642KUS$38.5M−40,322Sep 30, 2026
Mirum Pharmaceuticals, Inc.387KUS$33.1M+38,506Sep 30, 2026
United Therapeutics Corporation58,875US$31.9M−3,712Sep 30, 2026
Dyne Therapeutics, Inc.1.88MUS$30.3M+234KSep 30, 2026
Biogen Inc.133KUS$30M−7,361Sep 30, 2026
AnaptysBio, Inc.595KUS$29.9M−8,225Sep 30, 2026